Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate

Review

Abstract: As one of the major therapeutic options for cancer treatment, chemotherapy has limited selectivity a

Palabras claves:

Antibody-drug conjugates (ADCs), Bioconjugation, chemotherapy, Cytotoxic drug, FDA, Linker, Monoclonal antibody, Tumor

Autores:

Alberício F., B. G. De la Torre, Sheyi R.

Fuentes:

scopus